{
  "report_rows": [
    {
      "kpi": "Q2 revenue",
      "prediction": "MISS",
      "answer": "pred ~$2.68B vs. cons $2.73B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 adjusted operating EBITDA",
      "prediction": "IN-LINE",
      "answer": "pred ~$532M vs. cons $536M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 adjusted EPS ex-amortization",
      "prediction": "MISS",
      "answer": "pred ~$1.08 vs. cons $1.12",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 sales guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$10.65B vs. cons $10.67B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 adjusted operating EBITDA guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.10B vs. cons $2.10B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Food Ingredients sale net-proceeds commentary",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.8B vs. cons $3.8B (closing by Q2 2027)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -1.1,
  "day5_path": "FADE",
  "day5_rationale": "A modest sales/EPS shortfall and weak Scent mix should drive an initial de-risking, but retained FY2026 midpoint EBITDA guidance of ~$2.10B versus consensus ~$2.10B limits out-period estimate cuts; the initial reaction should partially fade as investors focus on price recovery and the ~$3.8B Food Ingredients proceeds.",
  "day5_confidence": "MEDIUM"
}